References
Bassi A, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut. 2004;53(10):1471–1478.
Thorpe KE. The rise in health care spending and what to do about it. Health Aff (Millwood). 2005;24(6):1436–1445.
Thorpe KE et al. The rising prevalence of treated disease: effects on private health insurance spending. Health Aff (Millwood); 2005. Suppl Web Exclusives: W5-317–W5-325.
Park KT, Bass, D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflamm Bowel Dis. 2011;17(7):1603–1609.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Toole, A., Harewood, G.C. Appropriateness of Laboratory Testing in Inflammatory Bowel Disease Inpatients: An Opportunity to Reduce Unnecessary Healthcare Costs. Dig Dis Sci 59, 295–296 (2014). https://doi.org/10.1007/s10620-013-2910-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-013-2910-8